Related Experiment Videos
Invader technology for DNA and RNA analysis: principles and applications
Monika de Arruda1, Victor I Lyamichev, Peggy S Eis
1Third Wave Technologies, 502 South Rosa Road, Madison, WI 53719-1256, USA. mdearruda@twt.com
Expert Review of Molecular Diagnostics
|September 26, 2002
Summary
The Human Genome Project and nucleic acid screening advance pharmacogenomics. The invader assay offers a simple, cost-effective solution for genotyping and gene expression monitoring, enabling personalized medicine.
Area of Science:
- Genomics
- Molecular Diagnostics
- Personalized Medicine
Background:
- Advances in the Human Genome Project and nucleic acid screening are expanding pharmacogenomic research.
- Current technologies for molecular diagnostics are often complex and costly, hindering personalized medicine.
- There is a need for accessible and scalable diagnostic tools.
Purpose of the Study:
- To introduce the invader assay as a solution for current limitations in pharmacogenomic research and molecular diagnostics.
- To highlight the assay's capabilities in genotyping and gene expression monitoring.
- To present a cost-effective and user-friendly alternative to existing technologies.
Main Methods:
- The invader assay was utilized for genotyping and gene expression monitoring.
- The assay functions without requiring intervening target amplification steps.
- Key performance indicators such as accuracy, simplicity, scalability, and cost-effectiveness were evaluated.
Main Results:
- The invader assay demonstrated accuracy in both genotyping and gene expression monitoring.
- The assay is simple to implement and scalable for various applications.
- It offers a cost-effective solution compared to existing complex technologies.
Conclusions:
- The invader assay provides an immediate, accurate, and cost-effective solution for pharmacogenomic research and molecular diagnostics.
- Its simplicity and scalability make it a valuable tool for advancing personalized medicine.
- The assay overcomes the limitations of current restrictive technologies.